Crossbeta Biosciences' Acquisition

Crossbeta Biosciences was acquired by ImmunoPrecise Antibodies on December 22, 2017.

Crossbeta is a privately held company based in the Netherlands with a proprietary technology for efficient oligomer-based drug discovery, with applications in Alzheimer's, Parkinson's, ALS and Hunting…

Articles about Crossbeta Biosciences' Acquisition: